π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
To assess the effect of a single doses of 20 mg ambroxol hydrochloride on c...
Status
Completed
Location
Castle Hill Hospital
Start Date
2018-02-15
Trial ID
NCT03415269
Treatments Being Tested
The purpose of this trial is to investigate efficacy and tolerability of lo...
Status
Completed
Location
Medicover
Start Date
2005-10
Trial ID
NCT00148499
Treatments Being Tested
Ambroxol is a simple cough medicine that is predicted to slow ALS disease p...
Status
Unknown
Location
Brain and Mind Centre
Start Date
2023-06-13
Trial ID
NCT05959850
Study to determine the basic pharmacokinetics of ambroxol and \[14C\]-radio...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT02194257
Treatments Being Tested
This study is a multicenter, randomized, double-blind, placebo-controlled c...
Status
Recruiting
Location
Ruijin Hospital affiliated to Shanghai Jiao Tong University
Start Date
2025-01-20
Trial ID
NCT06693362
Treatments Being Tested
This randomized controlled trial evaluated the clinical effect of fiberopti...
Status
Completed
Location
Benha University
Start Date
2023-12-15
Trial ID
NCT07149909
Treatments Being Tested
Ambroxol is a mucolytic containing an active N-desmethyl metabolite of brom...
Status
Completed
Location
Hospital Canselor Tuanku Muhriz UKM (HCTM)
Start Date
2023-01-07
Trial ID
NCT05663905
Treatments Being Tested
The purpose of this study is to evaluate the drug-durg interaction between ...
Status
Completed
Location
Samsung medical center
Start Date
2012-02
Trial ID
NCT01573663
Treatments Being Tested
This study will evaluate the safety, tolerability and pharmacodynamics of a...
Status
Completed
Location
Leonard Wolfson Experimental Neurology Centre Clinical Research Facility LWENC CRF
Start Date
2016-12
Trial ID
NCT02941822
Treatments Being Tested
The aim of this trial is to investigate the efficacy and tolerance of Ambro...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2007-08-01
Trial ID
NCT00525044